Alps Advisors Inc. grew its holdings in Cigna Corporation (NYSE:CI) by 18.3% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 6,466 shares of the health services provider’s stock after buying an additional 1,001 shares during the quarter. Alps Advisors Inc.’s holdings in Cigna Corporation were worth $1,209,000 as of its most recent SEC filing.
Several other institutional investors have also bought and sold shares of CI. Capstone Investment Advisors Netherlands B.V. purchased a new stake in shares of Cigna Corporation during the second quarter worth approximately $106,000. Saratoga Research & Investment Management purchased a new stake in shares of Cigna Corporation during the third quarter worth approximately $112,000. Parallel Advisors LLC increased its position in shares of Cigna Corporation by 62.3% during the second quarter. Parallel Advisors LLC now owns 800 shares of the health services provider’s stock worth $139,000 after purchasing an additional 307 shares in the last quarter. Acrospire Investment Management LLC increased its position in shares of Cigna Corporation by 66.7% during the second quarter. Acrospire Investment Management LLC now owns 1,000 shares of the health services provider’s stock worth $167,000 after purchasing an additional 400 shares in the last quarter. Finally, Financial Architects Inc increased its position in shares of Cigna Corporation by 186.0% during the second quarter. Financial Architects Inc now owns 1,121 shares of the health services provider’s stock worth $188,000 after purchasing an additional 729 shares in the last quarter. Institutional investors and hedge funds own 89.69% of the company’s stock.
Cigna Corporation (CI) opened at $197.61 on Tuesday. Cigna Corporation has a 12 month low of $131.03 and a 12 month high of $206.45. The company has a market capitalization of $48,811.91, a price-to-earnings ratio of 19.07, a PEG ratio of 1.51 and a beta of 0.49. The company has a quick ratio of 0.39, a current ratio of 0.39 and a debt-to-equity ratio of 0.37.
Cigna Corporation (NYSE:CI) last announced its quarterly earnings results on Thursday, November 2nd. The health services provider reported $2.83 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $2.36 by $0.47. Cigna Corporation had a return on equity of 18.85% and a net margin of 5.74%. The business had revenue of $10.38 billion for the quarter, compared to analyst estimates of $10.17 billion. During the same quarter in the prior year, the company posted $1.94 EPS. The company’s quarterly revenue was up 5.1% on a year-over-year basis. sell-side analysts expect that Cigna Corporation will post 10.34 earnings per share for the current year.
Several analysts recently commented on CI shares. Jefferies Group LLC boosted their price target on Cigna Corporation from $221.00 to $231.00 and gave the stock a “buy” rating in a research report on Friday, November 3rd. Zacks Investment Research upgraded Cigna Corporation from a “hold” rating to a “buy” rating and set a $214.00 price target for the company in a research report on Monday, October 9th. Citigroup Inc. boosted their price target on Cigna Corporation from $198.00 to $231.00 and gave the stock a “buy” rating in a research report on Friday, November 3rd. BMO Capital Markets initiated coverage on Cigna Corporation in a report on Monday, October 16th. They issued a “market perform” rating and a $210.00 target price for the company. Finally, BidaskClub cut Cigna Corporation from a “strong-buy” rating to a “buy” rating in a report on Monday, July 31st. Three equities research analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and one has given a strong buy rating to the stock. Cigna Corporation has a consensus rating of “Buy” and a consensus price target of $201.50.
In related news, Director William D. Zollars sold 1,232 shares of the stock in a transaction dated Wednesday, September 13th. The stock was sold at an average price of $187.23, for a total transaction of $230,667.36. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, EVP Lisa R. Bacus sold 2,236 shares of the stock in a transaction dated Wednesday, August 16th. The stock was sold at an average price of $179.95, for a total value of $402,368.20. Following the transaction, the executive vice president now directly owns 18,501 shares in the company, valued at approximately $3,329,254.95. The disclosure for this sale can be found here. In the last ninety days, insiders sold 4,290 shares of company stock worth $792,090. Corporate insiders own 1.30% of the company’s stock.
COPYRIGHT VIOLATION NOTICE: This report was first posted by Transcript Daily and is the property of of Transcript Daily. If you are accessing this report on another publication, it was copied illegally and reposted in violation of U.S. & international copyright and trademark laws. The legal version of this report can be read at https://transcriptdaily.com/2017/11/14/cigna-corporation-ci-stake-increased-by-alps-advisors-inc.html.
Cigna Corporation Profile
Cigna Corporation (Cigna), together with its subsidiaries, is a health services company. The Company offers medical, dental, disability, life and accident insurance and related products and services. The Company’s segments include Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations and Corporate.
Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Corporation (NYSE:CI).
Receive News & Ratings for Cigna Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Corporation and related companies with MarketBeat.com's FREE daily email newsletter.